New England Research & Management’s Sanofi SNY Stock Holding History

New England Research & Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,592	Closed	-$205K	–	182
2018 Q3	$205K	Buy	+4,592	New	+$196K	0.13%	154
2017 Q4	–	Sell	-4,592	Closed	-$229K	–	164
2017 Q3	$229K	Hold	4,592	–	–	0.17%	137
2017 Q2	$220K	Hold	4,592	–	–	0.16%	147
2017 Q1	$208K	Buy	+4,592	New	+$195K	0.16%	155
2015 Q4	–	Sell	-4,500	Closed	-$214K	–	175
2015 Q3	$214K	Hold	4,500	–	–	0.2%	149
2015 Q2	$223K	Sell	4,500 -2,100	-32%	-$106K	0.18%	155
2015 Q1	$326K	Hold	6,600	–	–	0.28%	124
2014 Q4	$301K	Buy	+6,600	New	+$320K	0.26%	139

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

New England Research & Management's SNY Position: Q4 2018 in Review

New England Research & Management sold out of Sanofi (SNY) in Q4 2018, closing a stake of 4,592 shares — an estimated $205K sold.

New England Research & Management first reported a position in SNY in Q4 2014 and held it in 8 quarters. The position peaked at $326K in Q1 2015. 501 funds tracked by Wall St. Rank hold SNY as of Q4 2018.

New England Research & Management reported no remaining Sanofi position as of Q4 2018 after selling out during the quarter.
New England Research & Management sold 4,592 Sanofi shares in Q4 2018, an estimated $205K.
New England Research & Management first reported a position in Sanofi in Q4 2014 and held it in 8 quarters.
New England Research & Management's Sanofi position peaked at $326K in Q1 2015.
501 funds tracked by Wall St. Rank held Sanofi as of Q4 2018.

Based on New England Research & Management's 13F filing for Q4 2018, filed 11 Jan 2019.